MNDR FY2025 TL;DR Summary (Year Ended June 30, 2025)
Financial Performance & Liquidity Crisis Revenue contracted sharply by 45.3% to \(7.65M (FY2024: \)13.97M), driven by post-COVID declines in telemedicine transactions. Despite this top-line drop, the Net Loss significantly improved to \((3.38M)\) from \((15.60M)\) in FY2024, primarily due to drastic expense rationalization. Total operating expenses fell from \(18.24M to \)4.83M, while Share-Based Compensation expense plummeted from \(9.12M to \)0.41M. Significant staff salary accruals were cleared, reducing total payables by nearly 50%.
**CR
...